Live Breaking News & Updates on Limitations Associated|Page 6

Stay updated with breaking news from Limitations associated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Air Quality Monitoring System Market by Product, Sampling, Pollutants, User and Region - Global Fore

Air Quality Monitoring System Market by Product, Sampling, Pollutants, User and Region - Global Fore
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United States , Forbes Marshall , Asia Pacific , Laura Wood , Agilent Technologies Inc , Labrotek Ltd , Teledyne Technologies Incorporated , Perkinelmer Inc , Merck Kga , Tisch Environmental Inc , Hangzhou Zetian Technology Co , Testo Se Co , Office Hours Call , Power Generation Industries , E St Office Hours Call , Emerson Electric Co , Availability Of Alternate Monitoring Solutions , Honeywell International Inc , Merck Kgaa , Thermo Fisher Scientific Inc , Horiba Ltd , Air Quality Monitoring System Market , Particulate Matter , Power Plant , New Zealand , North America ,

Gesundheitssystem - "Die jungen Mediziner sind wählerischer"

Gesundheitssystem - "Die jungen Mediziner sind wählerischer"
wienerzeitung.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wienerzeitung.at Daily Mail and Mail on Sunday newspapers.

Bernhard Salzer , Petra Tempferredakteurin , Thomas Szekeres , Job Has Been , Initial Euphoria Was , Medizinstudium Asked , Ten Will , They Want , Combine Hospital , Coordination And , President Of The , Total Number , Thomas Czypionka According , Institute For , Regulated Working Hours , Nordic Countries Are Looking , Medical Profession , Austrians Matura , General Practitioners , Limitations Associated , Even Nurses , Pve Is Trailing , Security However , More Time , Patients Can , Basic Problem ,

Stem Cell Manufacturing Market by Product, Application, End-user and Region

The "Global Stem Cell Manufacturing Market by Product (Consumables, Instrument, HSCs, MSCs, iPSCs, ESCs), Application (Research, Clinical (Autologous, Allogenic), Cell & Tissue Banking), End-user (Pharma & Biotech, Hospitals, Tissue Bank), and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. ....

United States , Miltenyi Biotec Gmb , Asia Pacific , Merck Millipore , Cellgenix Gmb , Laura Wood , Venture Capital Investments In Stem Cell Research , Stemcell Technologies Inc , Fujifilm Holdings Corporation , Lonza Group , Biopharmaceutical Industries , Research Development , Anterogen Co , Terumo Corporation , European Union , Porter Five Forces Analysis , Takara Bio Group , Office Hours Call , Research Methodology , Research Funding , Collaborative Efforts In Cancer Research , Bio Techne Corporation , Company Profiles , E St Office Hours Call , Technology Analysis , Corning Inc ,

Surgalign Holdings, Inc. Announces First Quarter 2021 Results

Message :
Required fields
DEERFIELD, Ill., May 10, 2021 (GLOBE NEWSWIRE) Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today reported operating results for the first quarter of 2021.
Highlights:
Total global spine revenue of $23.3 million, compared to $27.1 million in the first quarter of 2020
Net loss from continuing operations of $15.2 million inclusive of approximately $3.2 million of non-recurring charges
Adjusted EBITDA loss of $9.8 million, compared to a loss of $20.1 million in the first quarter of 2020
Appointed Marc Mackey as Executive Vice President, Digital Surgery
Submitted premarket notification, 510(k) for the Holo Surgical intelligent guidance system ....

San Diego , United States , Baden Wüberg , Marc Mackey , Surgalign Holdings , Holo Surgical Inc , Copies Of The Company , Surgalign Holdings Inc , Spine Technologies , Executive Vice President , Holo Surgical , Terry Rich , Chief Executive Officer , Private Securities Litigation Reform Act , Consolidated Statements , Three Months , Adjusted Gross , Net Loss Applicable , Commons Shares , Net Income , Common Shares , Per Diluted Share , Net Income Applicable , Adjusted Net Income Per Diluted , Limitations Associated , Adjusted Net Income Applicable ,

Orthofix Reports First Quarter 2021 Results

Gross profit decreased $1.7 million to $79.7 million. Gross margin decreased to 75.5% compared to 77.7% in the prior year period.
Net loss was $(5.8) million, or $(0.30) per share, compared to net income of $25.7 million, or $1.32 per share in the prior year period. Adjusted net income was $3.4 million, or $0.17 per share, compared to adjusted net income of $1.7 million, or $0.09 per share in the prior year period.
EBITDA was $1.8 million, compared to $12.4 million in the prior year period. Adjusted EBITDA was $14.0 million, or 13.3% of net sales, compared to $11.4 million, or 10.9% of net sales, in the prior year period.
Liquidity
As of March 31, 2021, cash, cash equivalents, and restricted cash totaled $95.1 million compared to $96.8 million as of December 31, 2020. As of March 31, 2021, the Company had no borrowings under its five year $300 million secured revolving credit facility. Cash flow from operations decreased $10.0 million to $2.4 million, while ....

United States , Jon Serbousek , Drug Administration , University Of Modena , Orthofix Inc , Exchange Commission , Orthofix Medical Inc , Securities Exchange , European Union Medical Device Regulation , Orthofix President , Chief Executive Officer Jon , Months Ended March , Exclusive License , Pulsed Electromagnetic Field , Low Intensity Pulsed Ultrasound , Capacitive Coupling , Coronavirus Disease , Securities Exchange Act , Securities Act , Risk Factors , Annual Report , Consolidated Statements , Chief Operating Decision Maker , Adjusted Net Income , Limitations Associated , ஒன்றுபட்டது மாநிலங்களில் ,